SUBSCRIBE
SUBSCRIBE
News   FDA

Novartis International AG Diabetes Drug Galvus Approved in Europe

September 28, 2007 | 
1 min read
ZURICH, Sept 28 (Reuters) - Novartis AG's (NOVN.VX: Quote, Profile, Research) potential blockbuster diabetes treatment Galvus has been approved for use in the European Union, the Swiss drugmaker said on Friday.
FDA Approvals Europe
MORE ON THIS TOPIC
Trendy halftone collage. A hand holds a ringing alarm clock. Time, hurry up. Vector business concepts for graphic and web design, marketing and print materials, social media. Vector illustration
Regulatory
Two FDA Decisions for Regeneron’s Eylea HD Delayed Into Q4
August 21, 2025
 · 
2 min read
 · 
Tristan Manalac
Red rocket with clouds rising up as metaphor for business and financial growth, Success and financial developing, Business growth concept, paper cut style.
Gene therapy
Rocket Re-Ignites Phase II Trial After FDA Lifts Clinical Hold
August 20, 2025
 · 
2 min read
 · 
Dan Samorodnitsky
Silver Spring, MD, USA - June 25, 2022: The FDA White Oak Campus, headquarters of the United States Food and Drug Administration, a federal agency of the Department of Health and Human Services (HHS).
Cancer
FDA Looks To Raise Survival Bar for Cancer Drug Approvals in New Draft Guidance
August 20, 2025
 · 
2 min read
 · 
Tristan Manalac
Podcast
MAHA Report Emphasizes Vaccines, Safety Vexes Viking’s Obesity Win, Novo Gains Momentum
August 20, 2025
 · 
2 min read
 · 
Heather McKenzie